Skip to main content
logo
Access Bio, Inc. (KOSDAQ:950130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,570.00
0.00 (0.00%)
Sep 1, 2026, 3:30 PM KST

Access Bio Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-110,912-82,118-347.58-3,173346,670189,690
Depreciation & Amortization
13,61017,16020,07815,96010,8266,064
Loss (Gain) From Sale of Assets
1,611124.613.40.8840.6-19.12
Asset Writedown & Restructuring Costs
75,21046,4231,496-1,9431.08-
Loss (Gain) From Sale of Investments
3,9886,0745,072-1,067-12.55-
Loss (Gain) on Equity Investments
-237.77-----
Stock-Based Compensation
---977.51,195454.38
Provision & Write-off of Bad Debts
-1,122584.5856.73-66,354-2,40776,625
Other Operating Activities
-35,156-28,326-36,531-13,81062.93-7,174
Change in Accounts Receivable
-4,9904,33511,464140,948-31,612-102,046
Change in Inventory
-750.534,60831,40074,137-66,079-28,282
Change in Accounts Payable
3,455-628.43-2,1901,355-8,0515,000
Change in Unearned Revenue
47.62-44.79--544.92-120.56
Change in Other Net Operating Assets
-5,4102,625-10,598-250,368118,56423,043
Operating Cash Flow
-60,656-29,18319,904-103,882369,198163,477
Operating Cash Flow Growth
----125.84%358.68%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,396-1,791-2,051-18,615-18,753-34,079
Sale of Property, Plant & Equipment
3,685199.414.2198.361,48934.3
Cash Acquisitions
-18,864-----
Divestitures
----998.63-
Sale (Purchase) of Intangibles
-527.25-0.33-2.61-56.77-23.32-14.49
Sale (Purchase) of Real Estate
-0.7----121.7-15.5
Investment in Securities
-23,1864,807573.88-41,490-27,963-
Other Investing Activities
14,66518,57519,33414,4605,929-901.29
Investing Cash Flow
-25,61421,80017,469-46,491-37,754-34,930

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----14,71430,299
Total Debt Issued
----14,71430,299
Short-Term Debt Repaid
-----15,936-9,761
Long-Term Debt Repaid
--4,868-7,546-6,451-38,144-2,572
Total Debt Repaid
-36,150-4,868-7,546-6,451-54,079-12,333
Net Debt Issued (Repaid)
-36,150-4,868-7,546-6,451-39,36617,966
Issuance of Common Stock
---406.539.3115.01
Repurchase of Common Stock
-2,184---2,366-28,058-
Dividends Paid
----29,341--
Other Financing Activities
-55.9210.09-9.43-16,237-024.46
Financing Cash Flow
-38,390-4,858-7,556-53,989-67,41418,005

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-5,6481,510-4,062518.05-3,650-1,090
Miscellaneous Cash Flow Adjustments
0---0-0
Net Cash Flow
-130,308-10,73125,755-203,844260,379145,462

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-62,052-30,97417,853-122,498350,444129,398
Free Cash Flow Growth
----170.83%412.35%
Free Cash Flow Margin
-263.62%-99.10%15.88%-35.14%33.90%25.62%
Free Cash Flow Per Share
-1762.11-879.62719.10-3625.749259.213468.64
Levered Free Cash Flow
-32,629-24,79223,7581,508294,780111,287
Unlevered Free Cash Flow
-31,577-23,34225,9273,827298,675113,380

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
649.58660.121,0361,098950.78249.74
Cash Income Tax Paid
--1,635-5,57214,796124,09589,040
Change in Working Capital
-7,64710,89530,076-34,47412,822-102,164